sr141716 has been researched along with Seizures in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Fantegrossi, WE; Wilson, CD; Zheng, F | 1 |
| Andrade, P; Hiltunen, M; Kanninen, K; Malm, T; Natunen, T; Ndode-Ekane, XE; Nissinen, J; Pitkänen, A; Sallinen, J; Shatillo, O; Soares, JI | 1 |
| Calignano, A; Citraro, R; De Sarro, G; Ngomba, RT; Nicoletti, F; Russo, E; Scicchitano, F; Whalley, BJ | 1 |
| Arlt, H; Augé, F; Avenet, P; Beeské, S; Bergis, OE; Bert, L; Bertrand, T; Brittain, S; Didier, M; Escoubet, J; Even, L; Françon, D; George, P; Griebel, G; He, T; Houtmann, J; Jacquet, A; Leroy, T; Lopez-Grancha, M; Menet, V; Michot, N; Mikol, V; Pichat, P; Rak, A; Redon, N; Sun, F; Tolstykh, T; Vallée, F; Wiederschain, D; Yu, Q; Zhang, B | 1 |
| Chen, B; Chen, Z; Dai, Y; Feng, B; Hu, W; Shi, L; Tang, Y; Wang, S; Wang, Y; Wu, D; Xu, C; Zhang, X; Zhou, Y; Zhu, J | 1 |
| Liu, C; Wang, X; Wang, Y; Wei, N; Zhang, C; Zhang, JG; Zhang, K; Zhao, B | 1 |
| de Bruin, N; Heijink, L; Kruse, C; Lüttjohann, A; Perescis, MF; van Luijtelaar, G; van Rijn, CM; Vinogradova, L | 1 |
| Perescis, MF; van Luijtelaar, G; van Rijn, CM; Vinogradova, L | 1 |
| Shatskova, AB; van Rijn, CM; Vinogradova, LV | 1 |
| DeLorenzo, RJ; Martin, BR; Wallace, MJ | 1 |
| Adrian, R; Baratta, J; Giuffrida, A; Piomelli, D; Solbrig, MV | 1 |
11 other study(ies) available for sr141716 and Seizures
| Article | Year |
|---|---|
Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male mice.
Topics: Animals; Benzodiazepines; Cannabinoid Receptor Agonists; Cannabinoids; Convulsants; Diazepam; Electroencephalography; Humans; Indazoles; Indoles; Male; Mice; Naphthalenes; Pentylenetetrazole; Receptor, Cannabinoid, CB1; Rimonabant; Seizures; Substance-Related Disorders; Valine | 2022 |
Disease-modifying effect of atipamezole in a model of post-traumatic epilepsy.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Anticonvulsants; Axons; Body Temperature; Brain; Drug Evaluation, Preclinical; Epilepsy, Post-Traumatic; Imidazoles; Male; Motor Activity; Neuronal Plasticity; Neuroprotective Agents; Piperidines; Proof of Concept Study; Pyrazoles; Random Allocation; Rats, Sprague-Dawley; Recovery of Function; Rimonabant; Seizures; Spatial Memory | 2017 |
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations.
Topics: Animals; Anticonvulsants; Arachidonic Acids; Benzoxazines; Cannabinoid Receptor Agonists; Cerebral Cortex; Electroencephalography; Endocannabinoids; Epilepsy; Epilepsy, Absence; Injections, Intraventricular; Male; Morpholines; Naphthalenes; Neural Pathways; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant; Seizures; Somatosensory Cortex; Thalamus | 2013 |
Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents.
Topics: Acetylcholine; Administration, Oral; Analgesics; Animals; Arachidonic Acids; Binding Sites; Brain; Cannabinoid Receptor Antagonists; Carbamates; Chromatography, High Pressure Liquid; Crystallography, X-Ray; Disease Models, Animal; Electric Stimulation; Endocannabinoids; Enzyme Inhibitors; Glycerides; Hippocampus; Humans; Hydrolysis; In Vitro Techniques; Learning; Long-Term Potentiation; Mass Spectrometry; Memory, Short-Term; Mice; Mice, Inbred C57BL; Mice, SCID; Monoacylglycerol Lipases; Pain; Piperidines; Protein Structure, Tertiary; Pyrazoles; Rimonabant; Seizures; Sulfonamides | 2015 |
Transient increase of interleukin-1β after prolonged febrile seizures promotes adult epileptogenesis through long-lasting upregulating endocannabinoid signaling.
Topics: Aging; Animals; Benzoxazines; Cannabinoid Receptor Antagonists; Cyclohexanones; Gene Expression Regulation; Hippocampus; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Lipoprotein Lipase; Mice; Mice, Knockout; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; RNA, Small Interfering; Seizures; Seizures, Febrile; Signal Transduction; Tissue Culture Techniques | 2016 |
CB1 receptor antagonism prevents long-term hyperexcitability after head injury by regulation of dynorphin-KOR system and mGluR5 in rat hippocampus.
Topics: Animals; Brain Injuries; Hippocampus; Male; Pentylenetetrazole; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, Opioid, kappa; Rimonabant; Seizures | 2016 |
Cannabinoid antagonist SLV326 induces convulsive seizures and changes in the interictal EEG in rats.
Topics: Animals; Behavior, Animal; Brain; Cannabinoid Receptor Antagonists; Electroencephalography; Female; Male; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Seizures | 2017 |
Endocannabinoid system protects against cryptogenic seizures.
Topics: Administration, Oral; Animals; Brain; Cannabinoid Receptor Modulators; Disease Models, Animal; Drug Administration Schedule; Electroencephalography; Endocannabinoids; Female; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Seizures; Time Factors | 2011 |
Pro-epileptic effects of the cannabinoid receptor antagonist SR141716 in a model of audiogenic epilepsy.
Topics: Acoustic Stimulation; Acute Disease; Animals; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy, Reflex; Kindling, Neurologic; Limbic System; Male; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Seizures | 2011 |
Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity.
Topics: Animals; Anticonvulsants; Arachidonic Acids; Cannabinoid Receptor Modulators; Endocannabinoids; Fatty Acids, Unsaturated; Male; Mice; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Seizures | 2002 |
A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena.
Topics: Animals; Anticonvulsants; Arachidonic Acids; Basal Ganglia; Borna Disease; Cannabinoid Receptor Modulators; Convulsants; Disease Models, Animal; Endocannabinoids; Limbic System; Male; Movement Disorders; Naloxone; Narcotic Antagonists; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Inbred Lew; Receptor, Cannabinoid, CB1; Rimonabant; Seizures | 2005 |